glp-1 gastric emptying anesthesia and Anesthesia: Considerations and Cautions for CRNAs How should we approach patients

Description

Responding to the findings, Tam Fry, the chair of the National Obesity Forum, said: Orforglipron [could prove] itself as the treatment of choice for the very obese diabetic

Pharmas grip on pricing, prolonged development cycles, and lobbying power left patients with fewer choices

Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus

Poor sleep increases hunger hormones, worsens insulin resistance, and drives cravings for ultra-processed foods

Some practitioners believe glycine helps preserve lean muscle mass during rapid weight loss, though clinical evidence specifically supporting this benefit in GLP-1 patients remains limited